Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Accepts healthy volunteers Results available

A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age

ClinicalTrials.gov ID: NCT05975099

Public ClinicalTrials.gov record NCT05975099. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 1:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/2, Randomized, Observer-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety and Immunogenicity of Heptavalent mRNA-1975 (SR1-7) and Monovalent mRNA-1982 (SR1) in Parallel Against Lyme Disease in Healthy Participants 18 Through 70 Years of Age

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and immunogenicity in parallel of heptavalent mRNA-1975 and monovalent mRNA-1982 against Lyme disease in healthy adult participants.

Study identification

NCT ID
NCT05975099
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
ModernaTX, Inc.
Industry
Enrollment
807 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 26, 2023 (Actual)
Primary completion
May 30, 2025 (Actual)
Completion
May 30, 2025 (Actual)
Last update posted
Jul 30, 2026

2023 – 2025

United States locations

U.S. sites
20
U.S. states
15
U.S. cities
20
Facility City State ZIP Site status
Clinical Research Consulting, LLC Milford Connecticut 06460 —
Stamford Therapeutics Consortium Stamford Connecticut 06905 —
Chase Medical Research, LLC Waterbury Connecticut 06708 —
Encore Research Group-Jacksonville Center for Clinical Research Jacksonville Florida 32216 —
University Clinical Research-DeLand, LLC d/b/a Accel Research Sites Lake Mary Florida 32746 —
Clinical Research Atlanta, headlands LLC Stockbridge Georgia 30281 —
Johnson County Clin-Trials, Inc. (JCCT) Lenexa Kansas 66219 —
Centennial Medical Group Columbia Maryland 21045 —
Advanced Primary and Geriatric Care Rockville Maryland 20850 —
DM Clinical Research - Brookline Brookline Massachusetts 02445 —
Clinical Research Institute, Inc. Minneapolis Minnesota 55402 —
Meridian Clinical Research - Omaha Omaha Nebraska 68134 —
ActivMed Research LLC Newington New Hampshire 03801 —
Rochester Clinical Research, Inc. Rochester New York 14609 —
Lynn Health Science Institute Oklahoma City Oklahoma 73112 —
Hatboro Medical Associates/CCT Research Hatboro Pennsylvania 19040 —
Velocity Clinical Research Providence Providence Rhode Island 02886 —
Benchmark Research Fort Worth Texas 76135 —
DM Clinical Research Tomball Texas 77375 —
Charlottesville Medical Research Center, LLC Charlottesville Virginia 22911 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05975099, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 30, 2026 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05975099 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →